A Registry Study of Biomarkers in Heart Valve Disease

计划入组 200,000 人 · 首次发布于 2024 年 1 月 25 日

Personalised Decision Support for Heart Valve Disease

计划入组 169 人 · 首次发布于 2019 年 8 月 28 日

Research on Neurological Prognosis of Patients Undergoing Heart Valve Surgery

计划入组 30 人 · 首次发布于 2022 年 9 月 14 日

heart disease modulator (cardiometabolic diseases)

RA-123456

HuCo Heart

THUBRIKAR AORTIC VALVE INC

United States

HERSHEY VALVE CO., LTD.

Taiwan

VENUS MEDTECH-B

Hong Kong, China

Low-Frequency Ventilation During Cardiac Surgery Protects Lung Function

HeartSense Uncovers Hidden Cardiovascular Disease Burden in Underserved Communities

TAVR Rewrites Structural Heart Care as Heart Valve Devices Market Projects 11.2% CAGR Through 2032